Long-term outcomes of patients with COVID-19 treated with helmet noninvasive ventilation or usual respiratory support: follow-up study of the Helmet-COVID randomized clinical trial.
Yaseen M ArabiHasan M Al-DorziSara AldekhylSaad Al QahtaniSheryl Ann AbdukahilEman Al QasimMohammad Khulaif Al HarbiAyman KharabaTalal AlbrahimMohammed S AlshahraniAbdulrahman A Al-FaresAli Al BshabsheAhmed MadyZainab Al DuhailibHaifa AlgethamyJesna JoseMohammed Al MutairiOmar Al ZumaiHussain Al HajiAhmed AlaqeilyWedyan Al WehaibiZohair Al AseriAwad Al-OmariHaytham TlayjehAbdulaziz Al-Dawoodnull nullPublished in: Intensive care medicine (2023)
Helmet noninvasive ventilation did not reduce 180-day mortality or improve HRQoL compared to usual respiratory support among patients with acute hypoxemic respiratory failure due to COVID-19 pneumonia.
Keyphrases
- respiratory failure
- coronavirus disease
- sars cov
- extracorporeal membrane oxygenation
- positive airway pressure
- mechanical ventilation
- obstructive sleep apnea
- acute respiratory distress syndrome
- cardiovascular events
- respiratory syndrome coronavirus
- sleep apnea
- intensive care unit
- risk factors
- clinical trial
- coronary artery disease
- newly diagnosed